A Commentary on “Erector Spinae Plane Block Combined With Local Infiltration Analgesia for Posterior Lumbar Interbody Fusion: Prospective, Double-Blind, Randomized Controlled Trial”
Neurospine · 31.10.2026 · 23 (4) · 801-802
DOI: 10.14245/ns.26521906.0953 ↗Kurz gefasst
Kommentar in der Zeitschrift Neurospine, erschienen am 31.10.2026. Verfasst von Hiroyuki Katoh. Beteiligte Einrichtung: Department of Medical Education, Tokai University School of Medicine, Isehara, Japan. hero@tokai.ac.jp. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Opioid-sparing analgesia after lumbar fusion is now routine practice in many countries.Since its description in 2016, the erector spinae plane block (ESPB) has become one of the most widely adopted regional techniques in spine surgery, 1,2 but randomized evidence remains mixed.Lonjon et al. 3 found no benefit over placebo in noninstrumented surgery within an enhanced recovery pathway, and Zamudio et al. 4 found that a postoperative ESPB improved early pain scores without reducing morphine consumption after lumbar fusion.Most of these trials compared 2 arms, so they could not address whether ESPB adds anything to the wound infiltration analgesics that many surgeons already inject at closure.The trial by the Shanxi group addresses exactly that question.5 Its 4-arm, placebo-controlled, double-blind design-saline or ropivacaine for ESPB and for local infiltration analgesia (LIA), in a 2 × 2 arrangement-is the right architecture for separating the contribution of each technique.The combined regimen showed the most consistent benefit in the 182 of 188 randomized patients: lower movement pain through 24 hours, fewer rescue analgesic administrations than with placebo, and the numerically highest satisfaction rate, without an increase in adverse events.For rescue analgesia and satisfaction, adjusted pairwise significance was limited to the comparison with placebo.Two features of the data deserve emphasis.First, the opioid outcome should be read on the right scale.Postoperative sufentanil was calculated as a fixed 48-µg background infusion plus 5 µg per bolus, so consumption and pump activations are effectively the same measurement.The fixed infusion, a protocol choice, makes the relative difference look modest (63 µg vs. 53 µg), but it is noteworthy that the number of patient-driven boluses fell from 3 to 1.Second, the time to first bolus is the most informative outcome.Its median rose from 4.7 hours with placebo to 10-11 hours with either technique alone and to 25.8 hours when they were combined.Medians alone cannot show synergy, but the trial's factorial analysis of this restricted-time outcome-in which the 7 of 45 combined-group patients who needed no bolus within 48 hours were assigned 48 hours-estimated a greater-than-additive effect Neurospine
Autor:innen und Institutionen
- Department of Medical Education, Tokai University School of Medicine, Isehara, Japan. hero@tokai.ac.jp.
Zitieren
APA
Katoh, H. (2026). A Commentary on “Erector Spinae Plane Block Combined With Local Infiltration Analgesia for Posterior Lumbar Interbody Fusion: Prospective, Double-Blind, Randomized Controlled Trial”. Neurospine, 23(4), 801-802. https://doi.org/10.14245/ns.26521906.0953
Vancouver
Katoh H. A Commentary on “Erector Spinae Plane Block Combined With Local Infiltration Analgesia for Posterior Lumbar Interbody Fusion: Prospective, Double-Blind, Randomized Controlled Trial”. Neurospine. 2026;23(4):801-802. doi:10.14245/ns.26521906.0953
BibTeX
@article{Katoh2026,
author = {Katoh, Hiroyuki},
title = {A Commentary on “Erector Spinae Plane Block Combined With Local Infiltration Analgesia for Posterior Lumbar Interbody Fusion: Prospective, Double-Blind, Randomized Controlled Trial”},
journal = {Neurospine},
year = {2026},
volume = {23},
number = {4},
pages = {801--802},
doi = {10.14245/ns.26521906.0953}
}
EUVIMED